胺碘酮干预治疗恶性室性心律失常及心源性猝死疗效分析(3)
 |
| 第1页 |
参见附件。
[5] Carr BG，Kahn JM，Merchant RM，et al. Inter-hospital variability in post-cardiac arrest mortality[J]. Resuscitation，2009，79(80)：30-34.
[6] EI Sherif N，Scherlag BJ，Lazzara R. Electroide cather recording during malignant ventricular arrythmia following experimental acute myocardial ischemia. Evidence for re-entry due to conduction delay and block in ischemic myocardium[J]. Circulation，1975，46(51)：1003-1014.
[7] Schwartz PJ，La Rovere MT，Vaonli E. Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification[J]. Circulation，1992，85(1)：77-91.
[8] Goldberger Z，Lampert R. Implantable cardioverter-defibrillators：expanding indications and technologies[J]. JAMA，2006，23(295)：809-818.
[9] 吴学思. 2009美国《成人心力衰竭治疗指南更新》解读[J]. 中华内科杂志，2009，13(10)：807-808.
[10] Nattle S. Comparative mechanisms of action of antiarrhythmic drugs[J]. AM J Cardiol，1993，72(16)：13F-17F.
[11] The CASCADE investigators：The Cascade study-randomized anti-arrhythmic drug therapy in survivors of cardiac arrest in Seattle[J]. Am J Cardiol，1993，12(13)：442-449.
[12] Connolly SJ，Dorian P，Roberts RS，et al. Comparison of beta-blockers，amiodarone plus beta-blockers，or sotalor for prevention of shocks from implantable cardioverter defibrillators：the OPTIC Study：a randomized trial[J]. JAMA，2006，21(295)：165-171.
[13] 章慧洁. 索他洛尔治疗心律失常的临床观察[J]. 中国心脏起搏与心电生理杂志，2005，10(1)：89-90.
(收稿日期：2012-04-05 本文编辑：郭静娟)
您现在查看是摘要介绍页，详见PDF附件(2100kb)。